Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin and panic

C J Bell1, D J Nutt

  • 1Psychopharmacology Unit, University of Bristol.

The British Journal of Psychiatry : the Journal of Mental Science
|November 26, 1998
PubMed
Summary
This summary is machine-generated.

Selective serotonin reuptake inhibitors (SSRIs) are effective treatments for panic disorder, showing similar efficacy to tricyclic antidepressants (TCAs) but with better tolerability. Serotonin plays a complex role in panic disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human brain changes after first psilocybin use.

Nature communications·2026
Same author

Serotonergic psychedelics for depression: A comprehensive overview.

International review of neurobiology·2025
Same author

Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study.

Archives of suicide research : official journal of the International Academy for Suicide Research·2024
Same author

Psilocybin and Other Classic Psychedelics in Depression.

Current topics in behavioral neurosciences·2023
Same author

Canalization and plasticity in psychopathology.

Neuropharmacology·2022
Same author

Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.

Psychopharmacology·2021
Same journal

The pressurised leaky funnel: rethinking recruitment, selection and retention in the UK psychiatry workforce.

The British journal of psychiatry : the journal of mental science·2026
Same journal

Cutting through stigma: psychiatry and neurosurgery working together.

The British journal of psychiatry : the journal of mental science·2026
Same journal

A fourth pillar for evidence-based medicine: implications for psychiatry - CORRIGENDUM.

The British journal of psychiatry : the journal of mental science·2026
Same journal

Understanding negative perceptions of psychiatrists on social media: lessons from public discourse and professional self-reflection.

The British journal of psychiatry : the journal of mental science·2026
Same journal

Attachment-informed psychopharmacology in psychiatric care.

The British journal of psychiatry : the journal of mental science·2026
Same journal

Acceptability and accuracy of point-of-care monitoring of lithium levels.

The British journal of psychiatry : the journal of mental science·2026
See all related articles

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) are established treatments for panic disorder.
  • Selective serotonin reuptake inhibitors (SSRIs) are increasingly used, with recent studies supporting their efficacy.
  • Evidence suggests a significant role for serotonin in the pathophysiology of panic disorder.

Purpose of the Study:

  • To review the efficacy of serotonergic agents in treating panic disorder.
  • To compare the effectiveness and tolerability of SSRIs with other antidepressant classes.
  • To explore the complex relationship between serotonin and anxiety in panic disorder.

Main Methods:

  • Comprehensive review of clinical trials.
  • Inclusion of animal studies investigating serotonergic mechanisms.

Related Experiment Videos

  • Analysis of laboratory studies measuring serotonin levels and responses to challenges.

    • Main Results:

    • SSRIs demonstrate significant efficacy in treating panic disorder, with improvement rates of 60-70%.
    • SSRI effectiveness is comparable to TCAs and superior to placebo.
    • Other serotonergic agents have not shown similar efficacy, and the serotonin-anxiety relationship is complex.

    Conclusions:

    • SSRIs are the only consistently effective serotonergic agents for panic disorder.
    • SSRIs offer comparable benefits to TCAs with potentially better tolerability, crucial for chronic conditions.
    • While serotonin is implicated in panic disorder, the exact mechanisms are multifaceted, likely involving various brain regions and serotonin receptors.